Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

VANCERIL

BECLOMETHASONE DIPROPIONATE

Standard Dose
0.042MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview VANCERIL is listed in Drugs@FDA under application 017573 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.042MG/INH Sponsor SCHERING Submission history Latest submission status date: 2000-08-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview VANCERIL is listed in Drugs@FDA under application 017573 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.042MG/INH Sponsor SCHERING Submission history Latest submission status date: 2000-08-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
VANCERIL (BECLOMETHASONE DIPROPIONATE) | Drug Monograph | MedicHelpline